Sunitinib in pediatric patients with advanced gastrointestinal stromal tumor: results from a phase I/II trial

BACKGROUND: Sunitinib is approved for treatment of adults with imatinib-resistant gastrointestinal stromal tumor (GIST) or imatinib intolerance. METHODS: This single-arm, multicenter, multinational phase I/II clinical trial (NCT01396148) enrolled eligible patients aged 6 to < 18 years with advanc...

Full description

Saved in:
Bibliographic Details
Published in:Cancer Chemother Pharmacol
Main Authors: Verschuur, Arnauld C., Bajčiová, Viera, Mascarenhas, Leo, Khosravan, Reza, Lin, Xun, Ingrosso, Antonella, Janeway, Katherine A.
Format: Artigo
Language:Inglês
Published: Springer Berlin Heidelberg 2019
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6561985/
https://ncbi.nlm.nih.gov/pubmed/31006038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-019-03814-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items